EIP
CVS icon

Ellis Investment Partners’s CVS Health CVS Stock Holding History

Ellis Investment Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Sell
3,293
-54
-2% -$4.82K 0.05% 215
2026
Q1 		$240K Sell
3,347
-72
-2% -$5.55K 0.04% 238
2025
Q4 		$271K Buy
3,419
+34
+1% +$2.68K 0.05% 211
2025
Q3 		$255K Buy
3,385
+33
+1% +$2.26K 0.05% 206
2025
Q2 		$231K Buy
3,352
+31
+0.9% +$2.03K 0.04% 216
2025
Q1 		$225K Buy
+3,321
New +$199K 0.05% 214
2022
Q4 		– Sell
-351
Closed -$33K – 308
2022
Q3 		$33K Buy
351
+28
+9% +$2.77K 0.01% 432
2022
Q2 		$30K Hold
323
– – 0.01% 454
2022
Q1 		$32K Sell
323
-19
-6% -$2K 0.01% 463
2021
Q4 		$35K Buy
342
+70
+26% +$6.47K 0.01% 466
2021
Q3 		$23K Buy
272
+51
+23% +$4.27K 0.01% 492
2021
Q2 		$18K Hold
221
– – ﹤0.01% 530
2021
Q1 		$17K Sell
221
-377
-63% -$27.5K ﹤0.01% 511
2020
Q4 		$41K Buy
598
+57
+11% +$3.71K 0.01% 398
2020
Q3 		$31K Buy
541
+173
+47% +$10.8K 0.01% 426
2020
Q2 		$23K Buy
368
+2
+0.5% +$126 0.01% 442
2020
Q1 		$21K Sell
366
-758
-67% -$50.6K 0.01% 400
2019
Q4 		$83K Sell
1,124
-32,948
-97% -$2.31M 0.03% 265
2019
Q3 		$2.12M Sell
34,072
-382
-1% -$22.6K 0.77% 29
2019
Q2 		$1.89M Sell
34,454
-511
-1% -$27.5K 0.71% 29
2019
Q1 		$1.89M Buy
34,965
+3,212
+10% +$198K 0.77% 31
2018
Q4 		$2.15M Buy
+31,753
New +$2.37M 0.98% 26

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Ellis Investment Partners's CVS Position: Q2 2026 in Review

Ellis Investment Partners reduced its CVS Health (CVS) stake by 1.6% in Q2 2026, selling an estimated $4.82K and leaving 3,293 shares worth $341K. The position accounts for 0.05% of the portfolio, ranked #215.

Ellis Investment Partners first reported a position in CVS in Q4 2018 and has held it in 22 quarters since. The position peaked at $2.15M in Q4 2018. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Ellis Investment Partners held 3,293 shares of CVS Health worth $341K as of Q2 2026.
  • Ellis Investment Partners sold 54 CVS Health shares in Q2 2026, an estimated $4.82K.
  • CVS Health made up 0.05% of Ellis Investment Partners's portfolio in Q2 2026, its #215 holding.
  • Ellis Investment Partners first reported a position in CVS Health in Q4 2018 and has held it in 22 quarters since.
  • Ellis Investment Partners's CVS Health position peaked at $2.15M in Q4 2018.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Ellis Investment Partners's 13F filing for Q2 2026, filed 5 Aug 2026.